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The  genome  of  the  Caprine  Arthritis-Encephalitis  Virus  (CAEV)  encodes  the  polycistronic  precursor  pro-
tein p55gag.  Proteolytic  cleavage  of p55gag generates  the  viral  core  proteins.  Some  studies  suggest  that
the  CAEV  p55gag protein  contains  epitopes  or  antigenic  determinants  for these  core proteins.  This  work
reinforces  this  hypothesis  and  demonstrates  that  monoclonal  antibodies  (MAbs)  that  are directed  against
the capsid  protein  (p28)  of CAEV  are  also  reactive  against  the  precursor  p55gag protein  and  the interme-
diate  cleavage  products,  p44,  p36 and  p22.  The  major  activity  of  the  MAbs  was  directed  against  p28.  The
MAbF12  binding  site  in  p28 was  found  to  be a linear  epitope  with  a structure  that is  stable  after  SDSonoclonal antibodies
28
55gag
enaturing agents
treatment  and  remains  unaltered  after  -mercaptoethanol  (-ME)  treatment.  The  MAbF12  binding  site
in  the  p55gag,  p36  and  p22  proteins  was  found  to  be  a  linear  epitope  with  cross-linked  sulphide  bonds.
In  conclusion,  these  ﬁndings  suggest  that  the  p28  epitope  is  presented  differently  from  the epitope  in
the polycistronic  precursor  protein  p55gag. The  highly  immunogenic  p28  contains  a  linear  epitope  that
is  detergent-stable  and  is  not  altered  by  -ME  treatment,  whereas  the  p55gag epitope  contains  a  linear
epitope  susceptible  to  denaturing  agents.Caprine Arthritis-Encephalitis Virus (CAEV), a member of the
etroviridae family, genus Lentivirus,  causes a progressive and debil-
tating disease in goats that affects the mammary glands, lungs,
rain and joints (Goff, 2007).
The CAEV genome comprises two copies of single-stranded RNA
hat encodes the gag (matrix, capsid and nucleoprotein proteins),
nv (envelope glycoproteins) and pol (reverse transcriptase, inte-
rase and protease proteins) genes. The gag gene is expressed as
 Gag polyprotein (p55gag kDa). This polyprotein is cleaved during
r shortly after the virion buds from the surface of the cell. Cleav-
ge of the Gag polyprotein yields the capsid protein (CA, p28 kDa),
he matrix protein (MA, p19 kDa) and the nucleocapsid protein (NP,
16 kDa) (Gogolewski et al., 1985; Cheevers et al., 1988; Schoborg,
002; Goff, 2007).
p28 is the most abundant viral capsid protein (60 copies). Its
etection is the predominant immunodiagnostic test because it
s the ﬁrst protein that is immunologically recognised by infected
nimals and typically remains detectable for a long period of time
Cheevers et al., 1988). Recently, some researchers have reported
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that p55gag would be a possible candidate for immunodiagnostic
assays because it contains p28 and other precursor core protein
epitopes (Rosati et al., 1999; Konishi et al., 2010).
MAbs are highly speciﬁc reagents that recognise a single epi-
tope; thus, they are useful tools for identifying and characterising
viral proteins. The aim of the present study was to investigate the
molecular structure of the p28 and p55gag epitopes in CAEV using
MAbs and denaturant agents.
A CAEV viral strain (Brazilian isolate; Tigre et al., 2006) was
propagated in GSMC (Goat Synovial Membrane Culture) in Eagle’s
minimal essential medium (E-MEM, Gibco®, MA,  USA) supple-
mented with 2% foetal bovine serum (FBS, Gibco®, MA,  USA). The
infected cells, which were incubated at 37 ◦C, were harvested when
an 80% cytopathic effect was  observed (15 days). The cell culture
was  cleared of debris by centrifugation at 16,000 × g for 20 min at
10 ◦C. The supernatant (1000 ml)  was recovered, and the result-
ing pellet (cell-associated viral antigen; AgV) was resuspended in
2.5 ml  (1:400) phosphate buffered saline (PBS) and stored at −70 ◦C.
The supernatant (1000 ml)  was  concentrated by precipitation with
PEG 8000 according to Fontes et al. (2005), and the precipitate
Open access under the Elsevier OA license.(virus-PEG-precipitate, VPP) was  resuspended in a smaller volume
of PBS (1.25 ml,  1:800). Aliquots of this preparation were assayed
for viral infectivity in GSMC (105 TCID50/ml) and for protein con-
centration (Bio-Rad Protein assay, CA, USA).
rologi
(
a
f
n
w
h
(
i
F
t
e
O
i
T
(
L
i
H
t
s
b
b
H
p
ﬂ
w
t
n
V
3
i
a
w
H
w
t
c
L
t
U
2
w
a
w
2
l
(
l
T
w
M
a
S
i
d
2
w
c
v
f
1C.F.L. Brandão et al. / Journal of Vi
The AgV was submitted to SDS (AgV-SDS) and -ME  treatments
AgV--ME). The AgV was incubated for 10 min  at room temper-
ture in 0.1% SDS (v/v) (0.28 M),  with frequent homogenisations,
ollowed by centrifugation for 15 min  at 10,000 × g. The super-
atant was collected and stored at −70 ◦C (AgV-SDS). The AgV
as incubated at 37 ◦C for 45 min  in 1.2% -ME  (v/v) with brief
omogenisation and then stored at −70 ◦C until use (AgV--ME)
Harith et al., 1995; Bass et al., 2006).
For hybridoma production, four-week-old BALB/c mice were
njected intraperitoneally with 50 g of VPP emulsiﬁed with
reund’s complete adjuvant (Sigma–Aldrich, St. Louis, USA). At
wo-week intervals, three intraperitoneal injections of 25 g VPP
mulsiﬁed with Freund’s incomplete adjuvant were performed.
ne month later, mice were boosted with 25 g VPP in ster-
le saline solution (NaCl 0.15 M)  and sacriﬁced 4 days later.
heir spleen cells (5 ×106) were fused to SP2/0 myeloma cells
1 ×106) in 1 ml  of 50% (w/w) PEG 1540 (Sigma–Aldrich, St.
ouis, USA). After centrifugation, the pellet was resuspended
n Iscove’s modiﬁed medium supplemented with 10% FBS and
ypoxanthine–aminopterin–thymidine (Invitrogen, USA) and dis-
ributed into 96-well microplates. An indirect ELISA was  used to
creen the hybridoma supernatants for reactivity against CAEV (see
elow). The positive hybridomas were selected and cloned twice
y limiting dilution. The positive clones (F12, A9, B9, C7, G7 and
9) were expanded in a culture ﬂask. The cells were injected into
ristane-treated BALB/c mice (106 cells/mouse) to obtain ascitic
uid for Western blot and ELISA analyses. Isotyping of the MAbs
as performed using a commercial kit (Bio-Rad, CA, USA) according
o the manufacturer’s instructions.
Enzyme immunoassay was used for screening hybridoma super-
atants. Microtiter plates (NUNC, MaxisorpTM) were coated with
PP (3 g/well) diluted in carbonate buffer (15 mM Na2CO3,
5 mM NaHCO3, pH 9.6) and incubated overnight at 4 ◦C. A block-
ng solution of 5% powdered skim milk in PBS (SM-PBS) was
dded to each well and incubated for 1 h at 37 ◦C. Wells were
ashed 5 times with PBS containing 0.05% Tween 20 (PBS-T).
ybridoma supernatants were added to each well, and the plates
ere incubated overnight at 4 ◦C. After the wells were washed 5
imes, they were ﬁlled with 100 l horseradish peroxidase (HRP)-
onjugated anti-mouse IgG (1:5000 dilution, Sigma–Aldrich, St.
ouis, USA) and incubated for 1 h at 37 ◦C. For colour development,
he 3,3′,5,5′-tetramethylbenzidine (TMB) (Sigma–Aldrich, St. Louis,
SA) substrate was added. The reaction was allowed to develop for
0 min, and 0.125% hydroﬂuoric acid (IDDEX Lab. Inc., ME,  USA)
as added as stop solution. The absorbance values were measured
t 630 nm.
Polyclonal antibodies were obtained for comparative analysis
ith MAbs. A six-month-old female New Zealand rabbit weighing
 kg and seronegative against CAEV was subcutaneously inocu-
ated with 50 g of VPP emulsiﬁed in Freund’s complete adjuvant
Sigma–Aldrich, St. Louis, USA). After 20 days, the rabbit was inocu-
ated with 50 g of VPP emulsiﬁed in Freund’s incomplete adjuvant.
his procedure was repeated again after 20 days, and a ﬁnal bleed
as performed by cardiac puncture. For comparative analysis with
Abs, the polyclonal antiserum was assayed by Western blotting
nd ELISA.
Analysis of the viral proteins was performed using a 5–15% slab
DS-PAGE. Samples of VPP, AgV, AgV-SDS, AgV--ME  and mock-
nfected GSMC (30 g/well) were heated at 100 ◦C for 3 min  in
enaturing buffer (30 mM Tris, pH 6.8, 10% 2--mercaptoethanol,
% SDS, 10% glycerol and 0.01% bromophenol blue). Molecular
eight markers (Low molecular weight range; Amersham Pharma-
ia Biotech, Brazil) were included in each run. After electrophoresis,
iral proteins were stained with Coomassie brilliant blue or trans-
erred to a nitrocellulose membrane by electroblotting (100 V,
 h). The membrane was cut into strips and blocked with SM-PBScal Methods 187 (2013) 352– 356 353
solution for 1 h at 37 ◦C. Then, the strips were incubated overnight
with each MAb  (1:10, ascitic ﬂuid) or rabbit polyclonal antiserum
(1:500) at 4 ◦C. After the membrane strips were washed 3 times
with PBS-T for 10 min, an HRP-conjugated goat anti-rabbit or anti-
mouse IgG (1:1000 dilution, Sigma–Aldrich, St. Louis, USA) was
added to detect bound antibodies. After a ﬁnal wash, the colour
development was  performed using a 3,3 diaminobenzidine (DAB)
solution at 10 mg/ml, which was  supplemented with fresh hydro-
gen peroxide to 0.08%. The membrane strips were dried and then
photographed.
The indirect ELISA test for MAbs was performed as described
by Torres et al. (2009) with some modiﬁcations. Brieﬂy, the
polystyrene plate (NUNC-MAXISORPTM) was  adsorbed with AgV,
AgV-SDS, AgV--ME  or control uninfected GSMC (3.0 g/well) in
carbonate buffer and incubated at 4 ◦C overnight. The plate was
then blocked with SM-PBS solution. Each MAb  (ascitic ﬂuid) and
the polyclonal antiserum were serially diluted (1:10 to 1:3200)
in SM-PBS solution supplemented with 0.3% Tween 20 and incu-
bated overnight. The MAbs and the polyclonal antiserum were
subsequently incubated with HRP-conjugated goat anti-mouse IgG
or HRP-conjugated anti-rabbit IgG (1:10,000, Sigma–Aldrich, St.
Louis, USA). For colour development, TMB  (Sigma–Aldrich, St. Louis,
USA) substrate was  added. The reaction was  allowed to develop for
20 min  and stopped with 0.125% hydroﬂuoric acid (IDDEX Lab. Inc.,
ME,  USA). The absorbance values were measured at 630 nm. Data
analysis was performed using the SPSS 16.0 software package for
Windows (SPSS Inc., Chicago, IL, USA). The Mann-Whitney non-
parametric test was  used to determine the statistically signiﬁcance
differences between AgV and denaturing treatments assessed using
ELISA (p = 0.05).
The following six hybridomas against CAEV were obtained: F12,
A9, G7, C7, B9 and H9. Isotype determination identiﬁed the six MAbs
as IgG1 kappa chain.
Western-blotting analysis revealed differences in MAb  reac-
tivity depending on the antigen preparation method. All of the
MAbs were reactive against p28 and showed a faint reaction to
p36 (36 kDa, intermediate product of p55gag cleavage) with VPP
(Fig. 1, Lane 2). However, with AgV, all of the MAbs were reactive
against p28 and several other proteins, such as p36, p44 and p55gag
(Fig. 1, Lane 1). These were all viral-speciﬁc bands because cross-
reactivity to mock-infected GSMC was not observed with the MAbs
(Fig. 1, Lane 3).
To characterise the p28 and p55gag epitopes, subsequent stud-
ies were performed to analyse AgV after denaturation. First, each
antigen preparation was comparatively analysed by protein elec-
trophoresis (Fig. 2). The protein pattern for AgV was identical after
SDS treatment. However, after AgV was treated with -ME, slight
differences were observed; speciﬁcally, faint protein bands larger
than 44 kDa were observed (Fig. 2A, Lines 1, 2 and 3). Second, after
denaturing, the reactivity of the MAbs against AgV was assessed
by Western blot analysis. Fig. 2B, Lane 1 shows the MAb  reactiv-
ity against AgV. The MAbs were reactive against several proteins,
such as p55, p44, p36, p28 and p22. After SDS treatment, the reac-
tivity proﬁle of the MAbs was the same as that of AgV, except that
a weak reaction to p44 was observed (Fig. 2B, Lane 2). A differ-
ent situation was observed using AgV--ME. MAb F12 maintained
reactivity only to the p28 and p44 proteins and was weakly reactive
to p55gag. The polyclonal antibody reactivity pattern was  assessed
by Western blot analysis and is shown in Fig. 2C. The polyclonal
antibodies more intensely recognised proteins larger than 40 kDa,
and the proﬁle of reactivity between AgV and AgV-SDS were not
signiﬁcantly different (not performed with AgV--ME).The comparative immunoreactivity of each MAb  to AgV, AgV-
SDS and AgV--ME  was evaluated using ELISA. As shown in Fig. 3, all
of the MAbs had high titres to AgV (≥1:3200). Conversely, the titres
decreased progressively when exposed to AgV-SDS or AgV--ME
354 C.F.L. Brandão et al. / Journal of Virological Methods 187 (2013) 352– 356
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(ig. 1. Western blot analysis of MAbs against CAEV. AgV (Lane 1), VPP (Lane 2) a
vernight incubation, HRP-conjugated goat anti-mouse IgG was added. The molecu
p < 0.05) with similar patterns of reactivity to AgV-SDS and AgV-
-ME (p > 0.05). MAbG7 demonstrated a different proﬁle, showing a
imilar reactivity pattern to AgV and AgV-SDS and low reactivity to
gV--ME  (p < 0.05). The reactivity pattern for the polyclonal anti-
erum is also depicted in Fig. 3. The polyclonal antiserum exhibited
 similar proﬁle, with high titres to AgV and AgV-SDS (≥1:3200)
not tested with AgV--ME). A cross-reactivity was observed to
on-infected GMSC at lowest dilutions.
The present study shows that all MAbs obtained against CAEV
eact strongly to p28, which is the most immunogenic viral core
rotein, but reactivity was not exclusive to p28. It was demon-
trated that the MAbs also reacted against p55gag, p44, p36 and
22. The multiple bands that were observed reﬂect the related anti-
enicity of all of these proteins. The p44, p36 and p22 viral proteins
re thought to be derived after the cleavage of p55gag during viral
aturation (Belov and Whalley, 1988; Schoborg, 2002). The role
f these intermediary proteins in the formation of the viral core
s unknown. Because of the disproportionate abundance of certain
roteins in the viral core (60 copies of p28), some authors sug-
est that cleavage of these intermediates could be involved in the
ormation of the viral protein core (Cheevers et al., 1988).
Depending on the location of the epitope, protein denaturation
ometimes alters the antigen-antibody binding site. Two  dena-
uring agents were used to study the molecular structure of the
pitope, an anionic surfactant (SDS), which linearises the pro-
ein structure (Filho and Volpe, 1994; Volpe and Perles, 2005),
nd -ME, which disrupts the cross-linked disulphide bonds (Cys
ig. 2. SDS-PAGE and Western blot analysis. Effect of denaturing treatments on viral prot
gV  (Lane 1), AgV-SDS (Lane 2) and AgV--ME  (Lane 3). (B) Reactivity of MAbF12 (ascit
Lane  3). (C) Reactivity of polyclonal antiserum by Western-blotting. AgV (Lane 1), AgV-Sock-infected GSMC (Lane 3). Each MAb  (ascitic ﬂuid) was diluted 1:10, and after
ights of the viral proteins are indicated on the left.
residues) (Harith et al., 1995; Bass et al., 2006). When the anti-
gen was subjected to denaturation, the epitope in p28 recognised
by the MAbF12 was not disrupted. This was true for both SDS
and -ME  treatments. These results suggest that the molecular
conformation or structure of the antibody binding site on the CA
protein is an epitope that is linear or continuous and does not
contain intramolecular disulphide bonds. This result suggests that
CAEV p28 resembles the HIV p24 protein binding site (falta bibli-
ograﬁa).
The denaturing treatment altered the recognition of p55gag
and the intermediate protein products; speciﬁcally, the SDS treat-
ment denatured the epitope in p44. Most likely, the molecular
structure of the p44 was linearised by the SDS treatment, and
the integrity of the conformation-dependent epitope was compro-
mised. Thus, the MAb  cannot bind if the epitope is denatured or
fragmented. Treatment with -ME  showed more dramatic results.
The epitopes in p55gag, p36 and p22 were not recognised by
the MAbF12 after treatment with -ME. -ME cleaves disulphide
bonds that are formed between Cys residues and denatures the pro-
tein (Harith et al., 1995). This ﬁnding suggests that the epitope in
these three proteins is associated with dimeric proteins or regions
that have cross-linked disulphide bonds, most likely in Cys-rich
regions.The binding activity of the MAbs after antigen denaturation was
also investigated by ELISA. The binding activity decayed with sta-
tistically signiﬁcant differences after the denaturing treatments,
and only one MAb  (MAbG7) showed a similar proﬁle between AgV
eins. (A) SDS-PAGE 5–15% under reducing conditions stained with Coomassie blue:
ic ﬂuid) by Western blot analysis. Ag-V (Lane 1), AgV-SDS (Lane 2) and AgV--ME
DS (Lane 2). The molecular weights of the viral proteins are indicated in the centre.
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nd AgV-SDS. Additionally, it was observed that MAbF12 and all
f the MAbs had a high immunoreactivity against AgV--ME. This
bservation was unexpected considering that the MAbF12 recog-
ised only p28 and p44, as previously determined by Western blot
nalysis. A possible explanation for this ﬁnding is that many pro-
eins undergo adsorption-induced conformational changes when
hey are adsorbed onto a polystyrene solid (Chen et al., 2004).
hese changes could interact or promote protein cross-linking that
ould alter or improve the reactivity of the epitope and could make
t accessible for MAb  binding. The binding activity of the poly-
lonal antiserum after antigen denaturation was also investigated
y ELISA. Conversely to MAbs, showed a similar proﬁle between
gV and AgV-SDS that was likely due to the similar patterns previ-
usly demonstrated by Western blotting.
In conclusion, the present work demonstrates that all MAbs
gainst CAEV are strongly reactive against p28 and its precursor
55gag. It was demonstrated with MAbF12 that the highly immuno-
enic p28 protein contains a linear epitope that is detergent-stable
nd is not altered by -ME  treatment, unlike the epitope in the
olyprotein precursor p55gag, which is susceptible to denaturing
reatments. These ﬁndings suggest that the p28 epitope is pre-
ented differently from the polyprotein precursor p55gag epitope.
imilar situations have been found for other lentiviruses, such as
IV and Equine Infectious Anaemia Virus (Henderson et al., 1987;
ussain et al., 1988; Truong et al., 1996). However, this report is
he ﬁrst that biochemically characterises the epitopes in the CAEV
28 and p55gag proteins using denaturing treatments.
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